Intra-Cellular Therapies, Inc.

BNP PARIBAS FINANCIAL MARKETS

Report date

3/31/2025

Quarter

2025 Q1

Filed

5/14/2025

Shares

247,848

Value ($000)

32,696

Weight

0.0%

2019 Q4 - 2025 Q1 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q1	5/14/2025	32,696	0.0%	247,848	3/31/2025
2024 Q4	2/14/2025	3,534	0.0%	42,310	12/31/2024
2024 Q3	11/13/2024	1,824	0.0%	24,923	9/30/2024
2024 Q2	8/13/2024	3,410	0.0%	49,784	6/30/2024
2024 Q1	5/1/2024	4,540	0.0%	65,608	3/31/2024
2023 Q4	2/14/2024	18,927	0.0%	264,276	12/31/2023
2023 Q3	11/14/2023	16,715	0.0%	320,888	9/30/2023
2023 Q2	8/9/2023	17,985	0.0%	284,039	6/30/2023
2023 Q1	5/12/2023	10,203	0.0%	188,416	3/31/2023
2022 Q4	2/14/2023	3,564	0.0%	67,344	12/31/2022
2022 Q3	11/16/2022	2,499	0.0%	53,714	9/30/2022
2022 Q2	8/12/2022	2,433	0.0%	42,624	6/30/2022
2022 Q1	5/18/2022	1,232	0.0%	20,133	3/31/2022
2021 Q4	2/9/2022	782	0.0%	14,944	12/31/2021
2021 Q3	11/16/2021	472	0.0%	12,654	9/30/2021
2021 Q2	8/10/2021	108	0.0%	2,648	6/30/2021
2021 Q1	5/7/2021	689	0.0%	20,316	3/31/2021
2020 Q4	2/10/2021	412	0.0%	12,965	12/31/2020
2020 Q3	10/30/2020	395	0.0%	15,389	9/30/2020
2020 Q2	8/6/2020	91	0.0%	3,544	6/30/2020
2020 Q1	5/13/2020	262	0.0%	17,030	3/31/2020
2019 Q4	2/12/2020	214	0.0%	6,233	12/31/2019